FACTX (FACTX) Stock Price & Analysis
FACTX (FACTX) rose 2.79% to USD 49.08 as of June 10, 2026 at 17:40 UTC, according to Nexqual real-time market data.
FACTX last closed at USD 47.75; the session ranged USD 49.08–49.08 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 44.84–58.9 (NAS). Source: Nexqual, June 10, 2026 at 17:40 UTC.
Key Statistics (as of June 10, 2026 at 17:40 UTC)
| Price | USD 49.08 |
|---|---|
| Change | ▲ 2.79% (up) |
| Previous Close | USD 47.75 |
| Open | USD 49.08 |
| Day Range | USD 49.08 – 49.08 |
| 52-Week Range | USD 44.84 – 58.9 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (FACTX)
Nexqual's technical model rates FACTX "BUY" based on 5 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 17:40 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 57.71 (neutral) |
| vs SMA50 | Above (USD 47.59) |
| MACD | 0.23 (positive) |
Financial Health Score (FACTX)
Nexqual rates FACTX's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 17:40 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FAFSX | Fidelity Advisor Financial Serv | USD 37.13 | ▲ 1.45% |
| FBTTX | Fidelity Advisor Biotechnology | USD 34.73 | ▲ 2.72% |
| FASPX | Fidelity Advisor Value Strategi | USD 55.78 | ▲ 0.9% |
| FAEGX | Fidelity Advisor Equity Growth | USD 23.48 | ▼ 0.51% |
| FSCTX | Fidelity Advisor Small Cap Fund | USD 30.54 | ▲ 1.5% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 17:40 UTC. This page is informational and not investment advice.